Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II/III Safety and Efficacy of GLASSIA in Subjects w/ Acute Graft-Vs-Host Gastrointestinal Involve

Protocol: OSU-16272

Full Title

A Two-Part, Multi-Center, Prospective, Phase 2/3 Clinical Study to Evaluate the Safety and Efficacy of GLASSIA as an Add-On Biopharmacotherapy to Conventional Steroid Treatment in Subjects with Acute Graft-Versus-Host Disease with Lower Gastrointestinal Involvement

Leukemia Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia Acute Myeloid Leukemia Hairy Cell Leukemia Chronic Lymphocytic Leukemia Lymphoma Cutaneous Lymphoma Hodgkin’s Lymphoma Non-Hodgkin’s Lymphoma (B- & T-Cell)